J. McElhaugh Michael's most recent trade in Arbutus Biopharma Corp was a trade of 718,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | Michael J. McElhaugh | Director, Interim President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 718,800 | 718,800 | - | - | Stock Option (Right to Buy) | |
| Arbutus Biopharma Corp | Michael J. McElhaugh | Director, Interim President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 177,000 | 1,658,003 (2%) | 0% | 0 | Common Shares | |
| Arbutus Biopharma Corp | Michael J. McElhaugh | Director, Interim President & CEO | Sale of securities on an exchange or to another person at price $ 3.28 per share. | 04 Feb 2025 | 23,790 | 1,481,003 (2%) | 0% | 3.3 | 78,103 | Common Shares |
| Arbutus Biopharma Corp | J. McElhaugh Michael | Director, Interim President & CEO | 01 Feb 2024 | 495,100 | 495,100 | - | - | Stock Option (Right to Buy) | ||
| Arbutus Biopharma Corp | J. McElhaugh Michael | Director, Interim President & CEO | 01 Feb 2024 | 123,800 | 1,514,957 (2%) | 0% | 0 | Common Shares | ||
| Arbutus Biopharma Corp | J. McElhaugh Michael | Director, Interim President & CEO | 01 Feb 2024 | 10,164 | 1,504,793 (2%) | 0% | 2.3 | 23,504 | Common Shares | |
| Arbutus Biopharma Corp | Michael J. McElhaugh | Chief Business Officer | 01 Feb 2023 | 334,700 | 334,700 | - | - | Stock Option (Right to Buy) | ||
| Arbutus Biopharma Corp | Michael J. McElhaugh | Chief Business Officer | 01 Feb 2023 | 83,700 | 1,391,157 (2%) | 0% | 0 | Common Shares | ||
| Arbutus Biopharma Corp | Michael J. McElhaugh | Chief Business Officer | 20 Jan 2022 | 325,850 | 325,850 | - | - | Stock Option (Right to Buy) | ||
| Arbutus Biopharma Corp | Michael J. McElhaugh | Chief Business Officer | 13 Feb 2021 | 249,000 | 249,000 | - | - | Stock Options | ||
| Arbutus Biopharma Corp | Michael J. McElhaugh | Chief Business Officer | 09 Feb 2021 | 20,000 | 1,307,457 (1%) | 0% | 5 | 100,000 | Common Stock | |
| Arbutus Biopharma Corp | Michael J. McElhaugh | Chief Business Officer | 14 Dec 2020 | 30,000 | 1,337,457 (1%) | 0% | 5 | 150,000 | Common Stock | |
| Arbutus Biopharma Corp | Michael J. McElhaugh | Chief Business Officer | 14 Dec 2020 | 10,000 | 1,327,457 (1%) | 0% | 5.0 | 50,032 | Common Stock | |
| Arbutus Biopharma Corp | Michael J. McElhaugh | Chief Business Officer | 23 Jul 2020 | 20,000 | 1,367,457 (1%) | 0% | 5.0 | 100,200 | Common Stock |